There is a general consensus among clinicians that a serum prostate-specific antigen (PSA) level ≥4.0 ng/ml is predictive of prostate cancer, and necessitates a biopsy. But there is a dearth of ...

PSA progression and PSA decline provide clinically meaningful information early during the treatment course of patients with metastatic prostate cancer who are unlikely to benefit from standard ...

Particularly in prostate cancer patients, this anxiety is often heightened when doctors observe elevated Prostate-Specific Antigen (PSA) levels. But the question is: do rising PSA levels after ...

Assessing prostate-specific antigen levels for 3 months after radical prostatectomy may help minimize overtreatment, according to findings in JAMA Oncology. Men with a persistent prostate-specific ...

One-third of patients with PSA levels below 0.2 ng/mL after radical prostatectomy have recurrent disease identifiable by PSMA PET. More than one-third of patients with PSA levels less than 0.5 ng ...

THURSDAY, March 27, 2025 (HealthDay News) — Assessment of prostate-specific antigen (PSA) level for three months after radical prostatectomy (RP) for prostate cancer may minimize overtreatment, ...

According to PSA, inbound submissions and in-progress orders for the impacted service levels are expected to be completed under original estimated turnaround times at the time of submission.

The BBC analysed five of these tests using one blood sample and found varying results: one positive, three negative, and one unreadable. PSA blood tests measures levels of PSA, a protein produced by ...

When David Bailey learned that he had prostate cancer, the retired school teacher did what teachers do best: he taught. He ...

For over 20 years the success of surgery to treat prostate cancer by removing the prostate gland has been monitored by measuring the level of a protein called prostate specific antigen (PSA ...